At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
Implant of Argus II Retinal Prosthesisdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Argus® II Retinal Stimulation System Feasibility Protocol
In Brief
A clinical study evaluating Implant of Argus II Retinal Prosthesis for Retinitis Pigmentosa. Completed, enrolled 30 participants across 12 sites in 5 countries.
Detailed Summary
Investigational Phase of the Study: The objective of this feasibility study is to evaluate the safety and utility of the Argus II Retinal Stimulation System in providing visual function to blind subjects with retinitis pigmentosa. Post-Approval Phase of the Study: To collect post-approval data in order to monitor the ongoing safety and reliability of the Argus II System
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRetinitis Pigmentosa
CountriesFrance, Mexico, Switzerland, United Kingdom, United States
CollaboratorsNational Eye Institute (NEI)
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 2006
First PostedDec 2006
Primary CompletionDec 2019
TodayJul 2026
First PostedDec 5, 2006
Enrollment StartSep 1, 2006
Primary CompletionDec 31, 2019
TodayJul 2, 2026
Enrollment to primary: 13.3 yearsPosted 19.6 years ago
Interventions
Implant of Argus II Retinal Prosthesisdevice
epiretinal implantation of device